Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
109 participants
INTERVENTIONAL
2020-01-29
2020-11-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aromatherapy Effect on Anxiety Prior to Ultrasound Guided Musculoskeletal Procedures
NCT05660486
Anxiety Reduction During Office Procedural Medicine Using Aromatherapy
NCT04260399
Effects of Aromatherapy on Anxiety in Invasive Radiologic Procedure
NCT03090750
Use of Inhaler Aromatherapy During SWL
NCT04848350
The Adjunctive Use of Lavender and Peppermint Essential Oils
NCT04934969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment (+aromatherapy) group
Activated Lavender Elequil aromatabs® (#372)
Activated Lavender aromatherapy tablets wrapped in tape
Control (-aromatherapy) group
Unactivated Lavender Elequil aromatabs® (#372)
Unactivated Lavender aromatherapy tablets wrapped in tape
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Activated Lavender Elequil aromatabs® (#372)
Activated Lavender aromatherapy tablets wrapped in tape
Unactivated Lavender Elequil aromatabs® (#372)
Unactivated Lavender aromatherapy tablets wrapped in tape
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Scheduled for one of the following procedures on the day of consent:
1. Epidural steroid injection (ESI)
2. Medial branch block (MBB)
3. Radiofrequency ablation (RFA)
3. Able to provide informed consent
Exclusion Criteria
2. Currently on anxiolytic therapy
3. Poor sense of smell
4. Allergy/aversion to aromatherapy
5. Non-English speaking
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaspal R Singh, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weill Cornell Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-06020284
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.